Stem Cell Manufacturing Market PPT: Demand, Trends and Business Opportunities 2023-28

1
Global Stem Cell Manufacturing Market Research
and Forecast Report 2023-2028

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled " Stem Cell Manufacturing Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2023-2028," the global stem cell
  manufacturing market size reached US 12.3
  Billion in 2022.
• Stem cells are unique types of undifferentiated
  cells in the human body that can develop into
  various specialized cell types. They have the
  potential to repair and regenerate damaged
  tissues and organs. They are commonly sourced
  from blood, bone marrow, umbilical cord, embryo,
  and placenta.
• Stem cells can be broadly categorized into
  embryonic and adult stem cells, offering distinct
  advantages and applications. Stem cells play a
  crucial role in tissue repair, regeneration, and
  maintaining the body's cellular balance.
  Moreover, they are widely used to treat various
  diseases, such as severe burns, arthritis,
  cancer, diabetes, lymphoma, neuroblastoma,
  leukemia, and multiple myeloma.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/stem-cell-manufacturing
  -market/requestsample

4
Report Description

• Global Stem Cell Manufacturing Market Trends
• The growing prevalence of chronic diseases and
  degenerative disorders has fueled the demand for
  innovative therapies, creating a positive outlook
  for the market growth. Stem cell-based treatments
  have demonstrated promising results in conditions
  like cardiovascular diseases (CVDs),
  neurodegenerative disorders, and autoimmune
  disorders. Moreover, the increasing need for
  regenerative therapies that can restore
  functionality and improve the quality of life for
  aging individuals is providing an impetus to the
  market growth. In addition to this, stem cell
  therapies hold the potential to provide
  personalized and targeted treatment approaches,
  thus garnering interest from both patients and
  healthcare providers.
• Additionally, the rise in public and private
  funding for stem cell research has spurred
  manufacturing technologies and process
  optimization advancements, such as induced
  pluripotent stem cell (iPSC) technology,
  facilitating the generation of patient-specific
  stem cells, reducing the risk of immune
  rejection, and enhancing treatment efficacy.
  Furthermore, the integration of advanced
  bioprocessing techniques and automation in stem
  cell manufacturing is encouraging manufacturers
  to actively invest in cutting-edge technologies
  to scale up production and improve product
  consistency, providing a considerable boost to
  the market growth. Other factors, including
  increasing application in tissue and organ
  replacement therapies, significant improvement in
  medical infrastructure, the implementation of
  various government initiatives promoting public
  health, are presenting remunerative growth
  opportunities for the market.
• Looking forward, the market value is projected to
  reach US 19.9 Billion by 2028, expanding at a
  CAGR of 8.1 during 2023-2028.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/stem-cell-manufacturing
  -market

5
Report Segmentation

• Breakup by Product
• Consumables
• Culture Media
• Others
• Instruments
• Bioreactors and Incubators
• Cell Sorters
• Others
• Stem Cell Lines
• Hematopoietic Stem Cells (HSC)
• Mesenchymal Stem Cells (MSC)
• Induced Pluripotent Stem Cells (iPSC)
• Embryonic Stem Cells (ESC)
• Neural Stem Cells (NSC)
• Multipotent Adult Progenitor Stem Cells

6
Report Segmentation

• Breakup by Application
• Research Applications
• Life Science Research
• Drug Discovery and Development
• Clinical Application
• Allogenic Stem Cell Therapy
• Autologous Stem Cell Therapy
• Cell and Tissue Banking Applications
• Breakup by End User
• Pharmaceutical Biotechnology Companies
• Academic Institutes, Research Laboratories and
  Contract Research Organizations
• Hospitals and Surgical Centers
• Cell and Tissue banks
• Others

7
Report Segmentation

• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

8
Competitive Landscape with Key Players

• Anterogen Co. Ltd.
• Becton Dickinson and Company
• Bio-Rad Laboratories Inc.
• Bio-Techne Corporation
• Corning Incorporated
• FUJIFILM Holdings Corporation
• Lonza Group AG
• Merck KGaA
• Sartorius AG
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Stem Cell
  Manufacturing Market    5.1    Market Overview 
    5.2    Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product
•   6.1    Consumables    6.1.1 Market
  Trends       6.1.2 Key Segments
•         6.1.2.1 Culture Media
•        6.1.2.2 Others
•        6.1.3 Market Forecast    6.2
  Instruments    6.2.1  Market Trends     
   6.2.2 Key Segments        6.2.2.1
  Bioreactors and Incubators       

11
Table of Contents

• 6.2.2.2 Cell Sorters
• 6.2.2.3 Others
• 6.2.3 Market Forecast
• 6.3 Stem Cell Lines
• 6.3.1 Market Trends
• 6.3.2 Key Segments
• 6.3.2.1 Hematopoietic Stem Cells (HSC)
• 6.3.2.2 Mesenchymal Stem Cells (MSC)
• 6.3.2.3 Induced Pluripotent Stem Cells
  (iPSC)
• 6.3.2.4 Embryonic Stem Cells (ESC)
• 6.3.2.5 Neural Stem Cells (NSC)
• 6.3.2.6 Multipotent Adult Progenitor
  Stem Cells
• 6.3.3 Market Forecast
• 7  Market Breakup by Application
• 7.1 Research Applications
• 7.1.1 Market Trends
• 7.1.2 Key Segments
• 7.1.2.1 Life Science Research
• 7.1.2.2 Drug Discovery and Development

12
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

13
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com